Clotrimazole
- Generic Name
- Clotrimazole
- Brand Names
- Alevazol, Dermacinrx Therazole Pak, Lotriderm, Lotrimin, Lotrimin AF, Lotrisone, Mycelex
- Drug Type
- Small Molecule
- Chemical Formula
- C22H17ClN2
- CAS Number
- 23593-75-1
- Unique Ingredient Identifier
- G07GZ97H65
- Background
This drug is a broad spectrum antimycotic or antifungal agent. Clotrimazole's antimycotic properties were discovered in the late 1960s . Clotrimazole falls under the imidazole category of azole antifungals, possessing broad-spectrum antimycotic activity . It is available in various preparations, including creams, pessaries, and troche formulations (slowly di...
- Indication
Topical preparations
Clotrimazole topical cream is indicated for the topical treatment of the following dermal infections , :
Tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum
Candidiasis due to Candida albicans
Tinea versicolor due to Malassezia furfur
...
- Associated Conditions
- Balanitis candida, Candidiasis, Dermatitis, Erythrasma, Fungal Vaginal Infections, Fungal ear infection, Fungal skin infection, Genital candidiasis, Inflammation, Mixed Vaginal Infections, Oropharyngeal Candidiasis, Pityriasis versicolor, Pyoderma, Ringworm, Skin Infections, Skin candida, Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea inguinalis, Trichophytosis, Vaginal Candidiasis, Vaginal Mycosis, Vulvitis, Cutaneous candidiasis, Infection mycotic, Susceptible Bacterial Infections, Symptomatic Tinea Corporis caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum, Symptomatic Tinea Cruris caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum, Symptomatic Tinea Pedis caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum, Tinea versicolor caused by Malassezia infection
- Associated Therapies
- -
B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
- Conditions
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients
- First Posted Date
- 2006-10-20
- Last Posted Date
- 2013-09-16
- Lead Sponsor
- Valerio Therapeutics
- Target Recruit Count
- 578
- Registration Number
- NCT00390780
- Locations
- 🇨🇦
Montreal General Hospital, Montreal, Quebec, Canada
🇨🇦University of Ottawa Health Services, Ottawa, Ontario, Canada
🇺🇸University of Connecticut, School of dental medicine, Farmington, Connecticut, United States
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
- Conditions
- Interventions
- First Posted Date
- 2004-03-02
- Last Posted Date
- 2018-06-29
- Lead Sponsor
- University of Wisconsin, Madison
- Target Recruit Count
- 10
- Registration Number
- NCT00078559
- Locations
- 🇺🇸
University of Wisconsin - Department of Medicine, Madison, Wisconsin, United States
Clotrimazole Enemas for Pouchitis in Children and Adults
- Conditions
- Interventions
- First Posted Date
- 2003-05-26
- Last Posted Date
- 2022-12-09
- Lead Sponsor
- Web
- Target Recruit Count
- 11
- Registration Number
- NCT00061282
- Locations
- 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002282
- Locations
- 🇺🇸
Dr Robert Larsen, Los Angeles, California, United States
🇺🇸SUNY / Health Sciences Ctr at Stony Brook, Stony Brook, New York, United States
🇺🇸Buckley Braffman Stern Med Associates, Philadelphia, Pennsylvania, United States
Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-02
- Target Recruit Count
- 500
- Registration Number
- NCT00000676
- Locations
- 🇺🇸
Northwestern University CRS, Chicago, Illinois, United States
🇺🇸Rush Univ. Med. Ctr. ACTG CRS, Chicago, Illinois, United States
🇺🇸Bmc Actg Crs, Boston, Massachusetts, United States
Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- University of North Carolina
- Target Recruit Count
- 20
- Registration Number
- NCT00004492
- Locations
- 🇺🇸
University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States
Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT00004404
- Locations
- 🇺🇸
Children's Hospital - Boston, Boston, Massachusetts, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.